Infant Bacterial Therapeutics AB (IFTBF)
6.18
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Infant Bacterial Therapeutics Shareholders Equity (Quarterly) : 8.668M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 8.668M |
| December 31, 2025 | 11.43M |
| September 30, 2025 | 13.22M |
| June 30, 2025 | 14.10M |
| March 31, 2025 | 15.28M |
| December 31, 2024 | 15.41M |
| September 30, 2024 | 20.13M |
| June 30, 2024 | 22.35M |
| March 31, 2024 | 25.94M |
| December 31, 2023 | 30.28M |
| September 30, 2023 | 31.85M |
| June 30, 2023 | 26.01M |
| March 31, 2023 | 29.82M |
| December 31, 2022 | 31.84M |
| September 30, 2022 | 33.50M |
| June 30, 2022 | 37.04M |
| March 31, 2022 | 40.35M |
| December 31, 2021 | 43.66M |
| September 30, 2021 | 47.03M |
| Date | Value |
|---|---|
| June 30, 2021 | 48.12M |
| March 31, 2021 | 50.56M |
| December 31, 2020 | 53.60M |
| September 30, 2020 | 51.96M |
| June 30, 2020 | 51.91M |
| March 31, 2020 | 51.63M |
| December 31, 2019 | 54.52M |
| September 30, 2019 | 54.71M |
| June 30, 2019 | 59.11M |
| March 31, 2019 | 59.95M |
| December 31, 2018 | 62.79M |
| September 30, 2018 | 65.32M |
| June 30, 2018 | 65.93M |
| March 31, 2018 | 70.35M |
| December 31, 2017 | 20.56M |
| September 30, 2017 | 9.680M |
| June 30, 2017 | 9.912M |
| March 31, 2017 | 10.83M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Orexo AB | 38.28M |
| Swedencare AB | 727.72M |
| Camurus AB | 464.22M |
| Moberg Pharma AB | 69.82M |
| AstraZeneca PLC | 47.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.02M |
| Total Liabilities (Quarterly) | 6.354M |
| Current Ratio | 2.233 |